histology; immunohistology; melanocytic hyperplasia; melanoma; surgical margin; Humans; Male; Female; Prospective Studies; Immunohistochemistry/methods; Middle Aged; Aged; Adult; Pilot Projects; Retrospective Studies; Aged, 80 and over; Melanoma/pathology; Melanoma/surgery; Melanoma/metabolism; Skin Neoplasms/pathology; Skin Neoplasms/surgery; Skin Neoplasms/metabolism; Margins of Excision; Immunohistochemistry; Skin Neoplasms; Oncology; Dermatology; Cancer Research
Abstract :
[en] Reexcisions for melanoma do rarely present residual melanoma. To analyze the number of positive margins in reexcisions of in situ and <1 mm melanomas. To see whether the immunohistochemical (IHC) panel (Preferentially expressed antigen of melanoma (PRAME), Sry-related HMg-Box gene 10 (SOX 10), Human melanoma black 45 (HMB45), and Melan A) detected additional cases of melanoma. Three pilot cohorts (retrospective, prospective, and direct safety margins) were analyzed on the persistence of melanoma in reexcisions. Among the 97 cases of the retrospective cohort (27 in situ and 69 invasive melanomas), one residual in situ melanoma was detected in the reexcisions. In the second cohort, among 81 cases (18 in situ and 63 invasive melanomas), two cases (2.5%) presented in situ melanoma. In the group where direct margins were taken ( n = 21) 2 (9.5%) in situ melanoma were evidenced in the margins. The IHC panel was needed to confirm three additional in situ melanomas in cohort 2. In a total of 178 cases (97 + 81) of reexcision, three and five cases (1.7 and 3.4%) of in situ melanoma were evidenced after H/E and IHC, respectively. These pilot data could question the usefulness of reexcision in <1 mm melanomas, particularly as only cases of in situ melanoma were detected. Larges prospective series would be required to answer this issue.
Disciplines :
Dermatology Laboratory medicine & medical technology
Author, co-author :
BOUILLENNE, Amandine ; Centre Hospitalier Universitaire de Liège - CHU > > Service de dermatologie ; Departments of Dermatology
Quatresooz, Pascale ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Histologie
Collins, Patrick; Dermatopathology, CHU du Sart Tilman, University of Liège, Liège, Belgium
Nikkels, Arjen F; CHU Liège - Centre Hospitalier Universitaire de Liège > Service de Dermatologie
Language :
English
Title :
Retro- and prospective histologic and immunohistochemical analysis of safety margins following complete excision of less than 1 mm melanomas.
1 ZijlkeraLPEggermontAMMvan AkkooieACJ. The end of wide local excision (WLE) margins for melanoma? Eur J Cancer 2023; 178:82–87.
2 FriedmanEBScolyerRAWilliamsGJThompsonJF. Melanoma in situ: a critical review and re-evaluation of current excision margin recommendations. Adv Ther 2021; 38:3506–3530.
3 JoyceKM. Chapter 7 Surgical management of melanoma. In Cutaneous melanoma. Etiology and Therapy; 2017. https://www.ncbi.nlm.nih.gov/books/NBK481850/.
4 HannaSLoSNSawRP. Surgical excision margins in primary cutaneous melanoma: a systematic review and meta-analysis. Eur J Surg Oncol 2021; 47:1558–1574.
5 GarbeCAmaralTPerisKHauschildAArenbergerPBasset-SeguinNet al.; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: update 2022. Eur J Cancer 2022; 170:236–255.
6 GarbeCAmaralTPerisKHauschildAArenbergerPBasset-SeguinNet al.; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - Update 2022. Eur J Cancer 2022; 170:256–284.
7 BellKJLSoyerHPFergusonPM. Is wide local excision after primary excision of melanoma in situ unnecessary? JAMA Dermatol 2025; 161:999–1001. doi: 10.1001/jamadermatol.2025.3077.
8 DessiniotiCBefonAPlakaMNiforouAKypreouKGellerACStratigosAJ. Local recurrence and survival in patients with melanoma in situ. JAMA Dermatol 2025; 161:1002–1006.
9 JackettLASatgunaseelanLRoperELoSNThompsonJFScolyerRA. Residual melanoma in wide local excision specimens after ‘complete’ excision of primary cutaneous in situ and invasive melanomas. Pathology (Phila) 2022; 54:71–78.
10 MaurichiABarrettaFPatuzzoRMiceliRGallinoGMattavelliIet al. Similar local recurrence and survival in patients with T1 radial growth phase melanoma on head and neck treated with 5 or 10 mm margins: A retrospective study. J Eur Acad Dermatol Venereol 2023; 37:1318–1326.
11 MaurichiABarrettaFPatuzzoRSalaLMiceliRGallinoGet al. Association of excision margin size with local recurrence and survival in patients with T1a melanoma at critical structures. JAMA Dermatol 2023; 159:587–595.
12 OjukwuKEguchiMMAdamsonASKerrKFPiepkornMWMurdochSet al. Immunohistochemistry for diagnosing melanoma in older adults. JAMA Dermatol 2024; 160:434–440.
13 MillerCJShinTMSobankoJFSharkeyJMGrunykJWElenitsasRet al. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas. J Am Acad Dermatol 2017; 77:333–340.e1.
14 NaminAWWelbyLBakerATDooleyLM. Positive margins in cutaneous melanoma of the head and neck: implications for timing of reconstruction. Otolaryngol Head Neck Surg 2021; 164:1052–1057.
15 KarponisDJoshyJStratigosIACraigPJMistryKvan BodegravenBet al. Cutaneous melanoma in situ: a review. Clin Exp Dermatol 2025; 50:529–536.
16 FarahMSuzukiSBhawanJ. Melanocytic hyperplasia associated with surgical scars in basal cell carcinoma re-excision specimens: a single-center retrospective study. J Cutan Pathol 2022; 49:7–16.
17 Martínez-FernándezSGonzález-SixtoBEspasandín-AriasMSoto-GarcíaDFlórezA. Topical and intralesional immunotherapy for melanoma in situ: a review. Cancers (Basel) 2023; 15:4468.
